Analysis Metabolite Name Measured Value Units Exercise Group Sex Type
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-57604Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-74177Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-77927Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-85012Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-89311Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-89788Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-91491Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-93308Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-94161Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-94972Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-95922Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-97438Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-98532Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-98578Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-98736Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-99619Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-99773Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-99850Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-99912Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-100234Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-100236Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-100477Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-100508Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-101023Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-102111Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-102170Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-102434Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-102561Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-102614Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-103564Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-103678Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-104107Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-104202Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-104925Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-104997Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105243Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105324Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105450Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105528Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105700Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-105951Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-106050Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-106507Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-106609Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-106697Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107015Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107044Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107090Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107186Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107428Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107446Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107601Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107716Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107768Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107860Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-107909Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108000Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108257Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108293Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108355Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108432Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108599Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108906Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-108915Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-109234Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-109958Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-109973Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110291Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110307Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110462Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110510Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110602Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-110785Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-111050Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-111057Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-111218Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-111674Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-111970Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112031Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112073Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112244Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112264Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112296Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112317Peak area normalizedNo Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112340Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112440Peak area normalizedYes Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112519Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112677Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112794Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112896Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-112930Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-113188Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-113450Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-113488Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-113814Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114141Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114157Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114256Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114319Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114355Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114454Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-114503Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115003Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115132Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115318Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115393Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115415Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115558Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115810Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-115979Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116028Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116044Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116142Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116216Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116381Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116557Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116575Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116579Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-116943Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117076Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117120Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117339Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117477Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117564Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-117860Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-118089Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-118091Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-118366Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-118782Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-118805Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119107Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119230Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119263Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119406Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119439Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119464Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119902Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-119928Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120042Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120151Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120323Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120394Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120860Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-120904Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121017Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121108Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121188Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121349Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121357Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121694Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121699Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-121730Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122167Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122254Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122325Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122401Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122457Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-122611Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123140Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123323Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123349Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123462Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123599Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123778Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123816Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123847Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123850Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-123864Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124186Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124488Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124743Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124765Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124780Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-124965Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-125387Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-125622Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-125641Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-126249Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-126511Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-126872Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-127218Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-127393Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-127674Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-127819Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-127887Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-128305Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-128341Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-128998Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-129220Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-129355Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-129491Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-129812Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-130888Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131325Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131344Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131538Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131585Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131772Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-131999Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-133282Peak area normalizedNo PAH Female Cath

Return to search page
  logo